Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04089553
Title An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca

prostate cancer


AZD4635 + Durvalumab

AZD4635 + Oleclumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.